Pulse Biosciences (PLSE)

• Market cap: $1.14B
• 1 day: 0.18%
• 5 days: -6.72%
• 1 month: -4.35%
• 3 months: 12.72%
• 6 months: -0.53%
• Year to date: -4.83%
• 1 year: -2.87%
• 5 years: 40.38%
• 10 years: 306%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Employees: 75